TY - JOUR
T1 - African American Patients with Chronic Rhinosinusitis Have a Distinct Phenotype of Polyposis Associated with Increased Asthma Hospitalization
AU - Mahdavinia, Mahboobeh
AU - Benhammuda, Mohamed
AU - Codispoti, Christopher D.
AU - Tobin, Mary C.
AU - Losavio, Philip S.
AU - Mehta, Arpita
AU - Jeffe, Jill S.
AU - Bandi, Sindhura
AU - Peters, Anju T.
AU - Stevens, Whitney W.
AU - Landay, Alan
AU - Keshavarzian, Ali
AU - Schleimer, Robert P.
AU - Batra, Pete S.
N1 - Publisher Copyright:
© 2016 American Academy of Allergy, Asthma & Immunology
PY - 2016/10/27
Y1 - 2016/10/27
N2 - Background: Chronic rhinosinusitis (CRS) is a common inflammatory disease of the upper airways that is often categorized into subtypes including “with” and “without” nasal polyps. However, the influence of multiple important epidemiologic factors, including race, on CRS has not been investigated. Objective: The present study assessed various phenotypic characteristics of CRS in patients, living in the United States, with different racial backgrounds. Methods: We performed a large retrospective cohort study of patients with CRS treated at a large urban tertiary care referral center in Chicago. Results: African American (AA) patients with CRS living in Chicago were more likely to report hyposmia as a symptom of CRS. Furthermore, AA patients with CRS who failed medical therapy and required surgical intervention had a significantly higher frequency of nasal polyposis and aspirin-exacerbated respiratory disease, and a higher disease severity index on computed tomography imaging than did white patients with CRS. The increased polyposis in AAs was associated with increased hospitalization for asthma. There were no differences in the prevalence of atopy, asthma, atopic dermatitis, food allergy, duration of disease, or number of surgeries between different races. Conclusions: AAs with refractory CRS are at increased risk for nasal polyposis, smell loss, aspirin-exacerbated respiratory disease, and a greater severity of disease based on imaging, resulting in increased health care utilization.
AB - Background: Chronic rhinosinusitis (CRS) is a common inflammatory disease of the upper airways that is often categorized into subtypes including “with” and “without” nasal polyps. However, the influence of multiple important epidemiologic factors, including race, on CRS has not been investigated. Objective: The present study assessed various phenotypic characteristics of CRS in patients, living in the United States, with different racial backgrounds. Methods: We performed a large retrospective cohort study of patients with CRS treated at a large urban tertiary care referral center in Chicago. Results: African American (AA) patients with CRS living in Chicago were more likely to report hyposmia as a symptom of CRS. Furthermore, AA patients with CRS who failed medical therapy and required surgical intervention had a significantly higher frequency of nasal polyposis and aspirin-exacerbated respiratory disease, and a higher disease severity index on computed tomography imaging than did white patients with CRS. The increased polyposis in AAs was associated with increased hospitalization for asthma. There were no differences in the prevalence of atopy, asthma, atopic dermatitis, food allergy, duration of disease, or number of surgeries between different races. Conclusions: AAs with refractory CRS are at increased risk for nasal polyposis, smell loss, aspirin-exacerbated respiratory disease, and a greater severity of disease based on imaging, resulting in increased health care utilization.
KW - African American
KW - Asthma
KW - Chronic rhinosinusitis (CRS)
KW - Nasal polyp
KW - Race
UR - http://www.scopus.com/inward/record.url?scp=84955315285&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955315285&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2015.11.031
DO - 10.1016/j.jaip.2015.11.031
M3 - Article
C2 - 26868728
AN - SCOPUS:84955315285
SN - 2213-2198
VL - 4
SP - 658-664.e1
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 4
ER -